Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 513 | 96 | 55 | N/A |
| Other current assets | 790 | 0 | 0 | 0 |
| TOTAL | $1,369 | $96 | $55 | $N/A |
| Non-Current Assets | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,369 | $96 | $55 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 2,186 | 952 | 540 | N/A |
| Accounts payable and accrued liabilities | 1,897 | 4,937 | 2,994 | 2,580 |
| Other current liabilities | N/A | 5 | 5 | N/A |
| TOTAL | $4,083 | $6,541 | $3,762 | $2,580 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,100 |
| TOTAL | $N/A | $N/A | $N/A | $1,100 |
| Total Liabilities | $4,083 | $6,541 | $3,762 | $3,680 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 610 | 588 | N/A | N/A |
| Common Shares | 1 | 0 | 0 | N/A |
| Retained earnings | -21,475 | -13,520 | -6,139 | -3,680 |
| TOTAL | $-2,714 | $-6,445 | $-3,707 | $-3,680 |
| Total Liabilities And Equity | $1,369 | $96 | $55 | $0 |